Copyright Reports & Markets. All rights reserved.

Global Sulfonamides Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Sulfonamides Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Intestinal Absorption
      • 1.4.3 Intestinal Tract Difficult to Absorb
      • 1.4.4 External Use
    • 1.5 Market by Application
      • 1.5.1 Global Sulfonamides Market Share by Application (2019-2025)
      • 1.5.2 Systemic Infection
      • 1.5.3 Intestinal Infection
      • 1.5.4 Burn Infection
      • 1.5.5 Other Infections
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Sulfonamides Market Size
    • 2.2 Sulfonamides Growth Trends by Regions
      • 2.2.1 Sulfonamides Market Size by Regions (2019-2025)
      • 2.2.2 Sulfonamides Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Sulfonamides Market Size by by Players
      • 3.1.1 Global Sulfonamides Revenue by by Players (2014-2019)
      • 3.1.2 Global Sulfonamides Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Sulfonamides Market Concentration Ratio (CR5 and HHI)
    • 3.2 Sulfonamides Key Players Head office and Area Served
    • 3.3 Key Players Sulfonamides Product/Solution/Service
    • 3.4 Date of Enter into Sulfonamides Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Sulfonamides Market Size by Type (2014-2019)
    • 4.2 Global Sulfonamides Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Sulfonamides Market Size (2014-2019)
    • 5.2 Sulfonamides Key Players in North America
    • 5.3 North America Sulfonamides Market Size by Type
    • 5.4 North America Sulfonamides Market Size by Application

    6 Europe

    • 6.1 Europe Sulfonamides Market Size (2014-2019)
    • 6.2 Sulfonamides Key Players in Europe
    • 6.3 Europe Sulfonamides Market Size by Type
    • 6.4 Europe Sulfonamides Market Size by Application

    7 China

    • 7.1 China Sulfonamides Market Size (2014-2019)
    • 7.2 Sulfonamides Key Players in China
    • 7.3 China Sulfonamides Market Size by Type
    • 7.4 China Sulfonamides Market Size by Application

    8 Japan

    • 8.1 Japan Sulfonamides Market Size (2014-2019)
    • 8.2 Sulfonamides Key Players in Japan
    • 8.3 Japan Sulfonamides Market Size by Type
    • 8.4 Japan Sulfonamides Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Sulfonamides Market Size (2014-2019)
    • 9.2 Sulfonamides Key Players in Southeast Asia
    • 9.3 Southeast Asia Sulfonamides Market Size by Type
    • 9.4 Southeast Asia Sulfonamides Market Size by Application

    10 India

    • 10.1 India Sulfonamides Market Size (2014-2019)
    • 10.2 Sulfonamides Key Players in India
    • 10.3 India Sulfonamides Market Size by Type
    • 10.4 India Sulfonamides Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Sulfonamides Market Size (2014-2019)
    • 11.2 Sulfonamides Key Players in Central & South America
    • 11.3 Central & South America Sulfonamides Market Size by Type
    • 11.4 Central & South America Sulfonamides Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Sulfonamides Introduction
      • 12.1.4 Pfizer Revenue in Sulfonamides Business (2014-2019))
      • 12.1.5 Pfizer Recent Development
    • 12.2 Sanofi
      • 12.2.1 Sanofi Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Sulfonamides Introduction
      • 12.2.4 Sanofi Revenue in Sulfonamides Business (2014-2019)
      • 12.2.5 Sanofi Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Sulfonamides Introduction
      • 12.3.4 Roche Revenue in Sulfonamides Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Mylan
      • 12.4.1 Mylan Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Sulfonamides Introduction
      • 12.4.4 Mylan Revenue in Sulfonamides Business (2014-2019)
      • 12.4.5 Mylan Recent Development
    • 12.5 Teva
      • 12.5.1 Teva Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Sulfonamides Introduction
      • 12.5.4 Teva Revenue in Sulfonamides Business (2014-2019)
      • 12.5.5 Teva Recent Development
    • 12.6 Bayer
      • 12.6.1 Bayer Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Sulfonamides Introduction
      • 12.6.4 Bayer Revenue in Sulfonamides Business (2014-2019)
      • 12.6.5 Bayer Recent Development
    • 12.7 Abbott
      • 12.7.1 Abbott Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Sulfonamides Introduction
      • 12.7.4 Abbott Revenue in Sulfonamides Business (2014-2019)
      • 12.7.5 Abbott Recent Development
    • 12.8 GlaxoSmithKline
      • 12.8.1 GlaxoSmithKline Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Sulfonamides Introduction
      • 12.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2014-2019)
      • 12.8.5 GlaxoSmithKline Recent Development
    • 12.9 Boehringer Ingelheim
      • 12.9.1 Boehringer Ingelheim Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Sulfonamides Introduction
      • 12.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2014-2019)
      • 12.9.5 Boehringer Ingelheim Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.
      In 2018, the global Sulfonamides market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Sulfonamides status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sulfonamides development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Pfizer
      Sanofi
      Roche
      Mylan
      Teva
      Bayer
      Abbott
      GlaxoSmithKline
      Boehringer Ingelheim

      Market segment by Type, the product can be split into
      Intestinal Absorption
      Intestinal Tract Difficult to Absorb
      External Use

      Market segment by Application, split into
      Systemic Infection
      Intestinal Infection
      Burn Infection
      Other Infections

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Sulfonamides status, future forecast, growth opportunity, key market and key players.
      To present the Sulfonamides development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Sulfonamides are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now